Spago Nanomedical AB (publ) 7UX.F Stock
Spago Nanomedical AB (publ) Price Chart
Spago Nanomedical AB (publ) 7UX.F Financial and Trading Overview
| Spago Nanomedical AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.05 EUR |
| Open | 0.06 EUR |
| Bid | 0.05 EUR x N/A |
| Ask | 0.06 EUR x N/A |
| Day's Range | 0.06 - 0.06 EUR |
| 52 Week Range | 0.05 - 0.17 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 5.39M EUR |
| Beta (5Y Monthly) | 1.912959 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7UX.F Valuation Measures
| Enterprise Value | 5.2M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Spago Nanomedical AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.912959 |
| 52-Week Change | -67.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.17 EUR |
| 52 Week Low | 0.05 EUR |
| 50-Day Moving Average | 0.06 EUR |
| 200-Day Moving Average | 0.09 EUR |
7UX.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 90.94M |
| Float | 72.67M |
| Short Ratio | N/A |
| % Held by Insiders | 25.78% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -251.56% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.77% |
| Return on Equity (ttm) | -24.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 112.00% |
| Gross Profit (ttm) | -13893000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.609 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Spago Nanomedical AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Scheelevägen 22 |
| ZIP | 223 63 |
| Phone | 46 4 68 11 88 |
| Website | https://spagonanomedical.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer; and Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
Q&A For Spago Nanomedical AB (publ) Stock
What is a current 7UX.F stock price?
Spago Nanomedical AB (publ) 7UX.F stock price today per share is 0.02 EUR.
How to purchase Spago Nanomedical AB (publ) stock?
You can buy 7UX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Spago Nanomedical AB (publ)?
The stock symbol or ticker of Spago Nanomedical AB (publ) is 7UX.F.
Which industry does the Spago Nanomedical AB (publ) company belong to?
The Spago Nanomedical AB (publ) industry is Biotechnology.
How many shares does Spago Nanomedical AB (publ) have in circulation?
The max supply of Spago Nanomedical AB (publ) shares is 400.91M.
What is Spago Nanomedical AB (publ) Price to Earnings Ratio (PE Ratio)?
Spago Nanomedical AB (publ) PE Ratio is now.
What was Spago Nanomedical AB (publ) earnings per share over the trailing 12 months (TTM)?
Spago Nanomedical AB (publ) EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Spago Nanomedical AB (publ) company belong to?
The Spago Nanomedical AB (publ) sector is Healthcare.